These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3133248)

  • 1. Purification and characterisation of two forms of toxin B produced by Clostridium difficile.
    Torres JF; Lönnroth I
    FEBS Lett; 1988 Jun; 233(2):417-20. PubMed ID: 3133248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production, purification and characterization of Clostridium difficile toxic proteins different from toxin A and from toxin B.
    Torres JF; Lönnroth I
    Biochim Biophys Acta; 1989 Oct; 998(2):151-7. PubMed ID: 2506935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterisation of toxin B from a strain of Clostridium difficile that does not produce toxin A.
    Torres JF
    J Med Microbiol; 1991 Jul; 35(1):40-4. PubMed ID: 1906544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical characterization and biologic actions of two toxins (D-1 and D-2) from Clostridium difficile.
    Banno Y; Kobayashi T; Kono H; Watanabe K; Ueno K; Nozawa Y
    Rev Infect Dis; 1984; 6 Suppl 1():S11-20. PubMed ID: 6426016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of toxin B from Clostridium difficile.
    Meador J; Tweten RK
    Infect Immun; 1988 Jul; 56(7):1708-14. PubMed ID: 3384474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of toxins A and B of Clostridium difficile.
    Sullivan NM; Pellett S; Wilkins TD
    Infect Immun; 1982 Mar; 35(3):1032-40. PubMed ID: 7068210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and properties of Clostridium difficile cytotoxin B.
    Pothoulakis C; Barone LM; Ely R; Faris B; Clark ME; Franzblau C; LaMont JT
    J Biol Chem; 1986 Jan; 261(3):1316-21. PubMed ID: 3944088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of Clostridium sordellii hemorrhagic toxin and cross-reactivity with Clostridium difficile toxin A (enterotoxin).
    Martinez RD; Wilkins TD
    Infect Immun; 1988 May; 56(5):1215-21. PubMed ID: 3128481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and some properties of cytotoxin produced by Clostridium difficile.
    Katoh T; Honda T; Miwatani T
    Microbiol Immunol; 1988; 32(6):551-64. PubMed ID: 3173147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of two high molecular weight toxins of Clostridium difficile which are antigenically related.
    von Eichel-Streiber C; Harperath U; Bosse D; Hadding U
    Microb Pathog; 1987 May; 2(5):307-18. PubMed ID: 2467163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of alpha-toxin of Clostridium oedematiens type A.
    Izumi N; Kondo H; Ohishi I; Sakaguchi G
    Jpn J Med Sci Biol; 1983 Jun; 36(3):135-46. PubMed ID: 6632349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simplified purification method for Clostridium difficile toxin A.
    Fu SW; Xue J; Zhang YL; Zhou DY
    World J Gastroenterol; 2004 Sep; 10(18):2756-8. PubMed ID: 15309736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterisation of Clostridium difficile toxin A by bovine thyroglobulin affinity chromatography and dissociation in denaturing conditions with or without reduction.
    Kamiya S; Reed PJ; Borriello SP
    J Med Microbiol; 1989 Sep; 30(1):69-77. PubMed ID: 2778794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterisation of intracellular toxin A of Clostridium difficile.
    Meng XQ; Kamiya S; Yamakawa K; Ogura H; Nakamura S
    J Med Microbiol; 1993 Jan; 38(1):69-73. PubMed ID: 8418298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of Clostridium sordellii lethal toxin and cross-reactivity with Clostridium difficile cytotoxin.
    Popoff MR
    Infect Immun; 1987 Jan; 55(1):35-43. PubMed ID: 3793234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of Clostridium difficile toxin A by affinity chromatography on immobilized thyroglobulin.
    Krivan HC; Wilkins TD
    Infect Immun; 1987 Aug; 55(8):1873-7. PubMed ID: 3112015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential cytotoxic effects of toxins A and B isolated from Clostridium difficile.
    Rothman SW; Brown JE; Diecidue A; Foret DA
    Infect Immun; 1984 Nov; 46(2):324-31. PubMed ID: 6500693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile toxin B: characterization and sequence of three peptides.
    Bisseret F; Keith G; Rihn B; Amiri I; Werneburg B; Girardot R; Baldacini O; Green G; Nguyen VK; Monteil H
    J Chromatogr; 1989 May; 490(1):91-100. PubMed ID: 2474559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fast purification of Clostridium sordellii cytotoxin.
    Baldacini O; Green GA; Girardot R; Rihn B; Monteil H
    J Chromatogr; 1990 Jun; 528(2):357-69. PubMed ID: 1696586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile.
    Lyerly DM; Barroso LA; Wilkins TD; Depitre C; Corthier G
    Infect Immun; 1992 Nov; 60(11):4633-9. PubMed ID: 1398977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.